{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:56:22Z","timestamp":1763157382632,"version":"3.45.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"DOI":"10.7759\/cureus.96853","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:54:31Z","timestamp":1763157271000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Role of Urine Cytology in Haematuria One-Stop Clinics: A Scoping Review of Current Evidence and Clinical Utility"],"prefix":"10.7759","author":[{"given":"Oluseyi H","family":"Ogunfusika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aretha","family":"Akinluyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad","family":"Elmadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tagelsir","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodeji O","family":"Adewoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The new NHS Modern and Dependable: A National Framework for Assessing Performance","year":"1998","unstructured":"The new NHS Modern and Dependable. A National Framework for Assessing Performance. Department of Health, London; 1998."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.09.078","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis R","year":"2012","unstructured":"Davis R, Jones JS, Barocas DA, et al.. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012, 188:2473-81. 10.1016\/j.juro.2012.09.078","journal-title":"J Urol"},{"key":"ref3","article-title":"Suspected Cancer: Recognition and Referral","year":"2015","unstructured":"Suspected Cancer. Recognition and Referral. 2015."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40763-4","article-title":"The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis","volume":"141","author":"Mariani AJ","year":"1989","unstructured":"Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989, 141:350-55. 10.1016\/S0022-5347(17)40763-4","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.05976.x","article-title":"A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic","volume":"97","author":"Edwards TJ","year":"2006","unstructured":"Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006, 97:301-5; discussion 305. 10.1111\/j.1464-410X.2006.05976.x","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67916-5","article-title":"A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"2","author":"Khadra MH","year":"200012025","unstructured":"Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE . A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 200012025, 2:524-7. 10.1016\/S0022-5347(05)67916-5","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/414125","article-title":"Haematuria: an imaging guide","volume":"2014","author":"Moloney F","year":"2014","unstructured":"Moloney F, Murphy KP, Twomey M, O'Connor OJ, Maher MM. Haematuria: an imaging guide. Adv Urol. 2014, 2014:414125. 10.1155\/2014\/414125","journal-title":"Adv Urol"},{"key":"ref8","article-title":"Urine cytology of transitional cell neoplasms","volume":"6","author":"Rife CC","year":"1979","unstructured":"Rife CC, Farrow GM, Utz DC. Urine cytology of transitional cell neoplasms. Urol Clin North Am. 1979, 6:599-612.","journal-title":"Urol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23656","article-title":"Diagnostic significance of 'atypia' in instrumented versus voided urine specimens","volume":"114","author":"Kapur U","year":"2008","unstructured":"Kapur U, Venkataraman G, Wojcik EM. Diagnostic significance of 'atypia' in instrumented versus voided urine specimens. Cancer. 2008, 114:270-4. 10.1002\/cncr.23656","journal-title":"Cancer"},{"key":"ref10","article-title":"Bladder Cancer: Diagnosis and Management","year":"2015","unstructured":"Bladder Cancer. Diagnosis and Management. 2015."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU Guideline","volume":"204","author":"Barocas DA","year":"2020","unstructured":"Barocas DA, Boorjian SA, Alvarez RD, et al.. Microhematuria: AUA\/SUFU Guideline. J Urol. 2020, 204:778-86. 10.1097\/JU.0000000000001297","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1308\/003588408X242006","article-title":"Is routine urine cytology useful in the haematuria clinic?","volume":"90","author":"Viswanath S","year":"2008","unstructured":"Viswanath S, Zelhof B, Ho E, Sethia K, Mills R. Is routine urine cytology useful in the haematuria clinic?. Ann R Coll Surg Engl. 2008, 90:153-5. 10.1308\/003588408X242006","journal-title":"Ann R Coll Surg Engl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjmsu.2010.04.002","article-title":"Three-year outcomes of a visible haematuria clinic\u2014no initial role for urine cytology?","volume":"3","author":"Munro NP","year":"2010","unstructured":"Munro NP, Stower MJ, Urwin, et al.. Three-year outcomes of a visible haematuria clinic\u2014no initial role for urine cytology?. Brit J Med Surg Urol. 2010, 3:204-9. 10.1016\/j.bjmsu.2010.04.002","journal-title":"Brit J Med Surg Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10664.x","article-title":"Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic","volume":"110","author":"Blick CG","year":"2012","unstructured":"Blick CG, Nazir SA, Mallett S, et al.. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. BJU Int. 2012, 110:84-94. 10.1111\/j.1464-410X.2011.10664.x","journal-title":"BJU Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14459","article-title":"Does urinary cytology have a role in haematuria investigations?","volume":"123","author":"Tan WS","year":"2019","unstructured":"Tan WS, Sarpong R, Khetrapal P, et al.. Does urinary cytology have a role in haematuria investigations?. BJU Int. 2019, 123:74-81. 10.1111\/bju.14459","journal-title":"BJU Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000446270","article-title":"The Paris system for reporting urinary cytology: the quest to develop a standardized terminology","volume":"60","author":"Barkan GA","year":"2016","unstructured":"Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, Rosenthal DL. The Paris system for reporting urinary cytology: the quest to develop a standardized terminology. Acta Cytol. 2016, 60:185-97. 10.1159\/000446270","journal-title":"Acta Cytol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines","volume":"87","author":"van der Heijden AG","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A, et al.. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines. Eur Urol. 2025, 87:582-600. 10.1016\/j.eururo.2025.02.019","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004490","article-title":"Updates to microhematuria: AUA\/SUFU Guideline (2025)","volume":"213","author":"Barocas DA","year":"2025","unstructured":"Barocas DA, Lotan Y, Matulewicz RS, et al.. Updates to microhematuria: AUA\/SUFU Guideline (2025). J Urol. 2025, 213:547-57. 10.1097\/JU.0000000000004490","journal-title":"J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420962-evaluating-the-role-of-urine-cytology-in-haematuria-one-stop-clinics-a-scoping-review-of-current-evidence-and-clinical-utility","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:54:32Z","timestamp":1763157272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420962-evaluating-the-role-of-urine-cytology-in-haematuria-one-stop-clinics-a-scoping-review-of-current-evidence-and-clinical-utility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.96853","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}